Genotype may correlate with liver carcinogenesis and tumor characteristics in cirrhotic patients infected with hepatitis B virus subtype adw

Journal of Medical Virology

Volumn 65, Issue 2, 2001, Pages 257-265

  Tsubota, Akihito ^a   Arase, Yasushi ^a   Ren, Fengrong ^b   Tanaka, Hiroshi ^c   Ikeda, Kenji ^d   Kumada, Hiromitsu ^d  

^a TORANOMON HOSPITAL   (Japan)

^b Okinaka Memorial Institute for Medical Research   (Japan)

^c JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Cirrhosis; Genotype; Hepatitis B virus; Hepatocellular carcinoma; Subtype; Transcatheter arterial embolization therapy

Indexed keywords

ADULT; AGED; ARTICLE; ARTIFICIAL EMBOLISM; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL ARTICLE; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GENETIC VARIABILITY; GENOTYPE; HEPATITIS B VIRUS; HUMAN; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FAILURE; MALE; POLYMERASE CHAIN REACTION; REGRESSION ANALYSIS; SEROLOGY; TREATMENT OUTCOME; TUMOR NECROSIS; VIRUS INFECTION; VIRUS TYPING;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; COHORT STUDIES; EMBOLIZATION, THERAPEUTIC; FEMALE; GENOTYPE; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; MIDDLE AGED; MUTATION; NEOPLASM RECURRENCE, LOCAL; PROMOTER REGIONS (GENETICS); PROSPECTIVE STUDIES; TREATMENT OUTCOME; VIRAL CORE PROTEINS;

EID: 0034878008     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmv.2028     Document Type: Article

References (46)

1. A case-control study of hepatocellular carcinoma and the hepatitis B virus, cigarette smoking, and alcohol consumption
2. Detection of additional antigenic determinants of hepatitis B antigen
3. Hepatocellular carcinoma and hepatitis B virus: A prospective study of 22,707 men in Taiwan
4. Genotypic differences in the hepatitis B virus core promoter and precore sequences during seroconversion from HBeAg to anti-HBe
5. Hepatitis B virus DNA in patients with chronic liver disease and negative tests for hepatitis B surface antigen
6. Different hepatitis B virus genotypes are associated with different mutations in the core promoter and precore regions during hepatitis B e antigen seroconversion
7. Hepatic artery embolization in the treatment of hepatic neoplasms
8. Distribution of HBsAg subtypes in the world
9. The hepatitis B virus large surface protein (LHBs) is a transcriptional activator
10. Effect of repeated transcatheter arterial embolization on the survival time in patients with hepatocellular carcinoma
11. A multivariate analysis of risk factors for hepatocellular carcinogenesis: A prospective observation of 795 cases with viral and alcoholic cirrhosis
12. Hepatitis B surface antigen particles of subtypes adw and adr, and compound subtype (adwr) in symptom-free carriers in Japan
13. Hepatitis B genotypes correlate with clinical outcomes in patients with chronic hepatitis B
14. Hepatitis B virus transactivator HBx uses a tumor promoter signaling pathway
15. The preS2/S region of integrated hepatitis B virus DNA encodes a transcriptional transactivator
16. Relationship between hepatocellular carcinoma and cirrhosis
17. Influence of subtype on the prognosis of chronic type B hepatitis
18. Significant difference in hepatitis B e antigen seronegativity rate between subtypes adr and adw in chronic hepatitis B
19. Hepatitis B virus and cigarette smoking: Risk factors for hepatocellular carcinoma in Hong Kong
20. t transactivator is generated by 3′ truncations within a defined region of the S gene
21. The heterogeneity of Australia antigen
22. Hepatitis B virus genotype A rarely circulates as an HBe-minus mutant: Possible contribution of a single nucleotide in the precore region
23. Hepatic arterial embolization in patients with unresectable hepatocellular carcinoma: A randomized controlled trial
24. Core promoter mutations and genotypes in relation to viral replication and liver damage in East Asian hepatitis B virus carriers
25. Primary liver cancer in Japan
26. Geographical distribution of Australia antigen determinants d, y and w
27. Comparison of the amino acid sequences of nine different serotypes of hepatitis B surface antigen and genomic classification of the corresponding hepatitis B virus strains
28. Genetic relatedness of hepatitis B viral strains of diverse geographical origin and natural variations in the primary structure of the surface antigen
29. Complete genomes, phylogenetic relatedness, and structural proteins of six strains of the hepatitis B virus, four of which represent two new genotypes
30. Point mutation in the S-gene of hepatitis B virus for a d/y or w/r subtypic change in two blood donors carrying a surface antigen of compound subtype adyr or adwr
31. Typing hepatitis B virus by homology in nucleotide sequence: Comparison of surface antigen subtypes
32. Estimates of worldwide frequency of twelve major cancers
33. Integration of hepatitis B virus DNA into the genome of liver cells in chronic liver disease and hepatocellular carcinoma
34. Relationship of HBsAg subtypes with HBeAg/anti-HBe status and chronic liver disease. Part I: Analysis of 1744 HBsAg carriers
35. A new genotype of hepatitis B virus: Complete genome and phylogenetic relatedness
36. Hepatocellular carcinoma and the hepatitis B virus: Evidence for a casual association
37. Deletions in the hepatitis B virus core gene may influence the clinical outcome in hepatitis B e antigen-positive asymptomatic healthy carriers
38. Risk factors for hepatocellular carcinoma among patients with chronic liver disease
39. Transcriptional trans-activating function of hepatitis B virus
40. Risk factors for hepatocellular carcinoma in Italy
41. Non-operative arterial embolization in primary liver tumours
42. A transactivating function encoded in the hepatitis B virus X gene is conserved in the integrated state
43. South-to-north gradient in distribution of the r determinant of hepatitis B surface antigen in Japan
44. The HBV X-ORF encodes a trans-activator: A potential factor in viral hepatocarcinogenesis
45. Risk factors in development of hepatocellular carcinoma in cirrhosis: Prospective study of 613 patients
46. Analysis of hepatitis B virus genotypes and pre-core region variability during interferon treatment of HBe antigen negative chronic hepatitis B